Medical and Pharmaceutical Industries
As the only industry group in existence that focuses on the scientific and regulatory aspects and policy needs of nanomedicines, the Alliance has the following vision and mission:
To catalyze the use of nanomedicines for patient benefit.
To promote and facilitate the scientific advancement, regulatory approval, safe use and public appreciation of nanotechnology-based medicines world-wide for the diagnosis, treatment and prevention of disease.
EastGate Pharmaceuticals produces and distributes innovative and healthy nutraceuticals that are based on natural therapies and absorbed naturally by the body.
EastGate Pharmaceuticalstials develops products in which the active components are incorporated into vehicles containing nano-sized delivery vectors, including: oil droplets (nanoemulsions), polymeric particles (nanoparticles), and the combination of polymers and lipids with surfactants (hybrid nanoparticles, nanocapsules, mixed micelles).
VTT Technical Research Centre of Finland Ltd is the leading research and technology company in the Nordic countries. VTT has a national mandate in Finland. We use our research and knowledge to provide expert services for our domestic and international customers and partners. We serve both private and public sectors.
We have 73 years’ experience supporting our clients growth with top-level research and science-based results.
At PEN, we’re harnessing nanotechnology, the science of the infinitely small, in products that have big impact on health, safety and sustainability. They perform better, faster, smarter, stronger, cleaner – to make every day better for people and the planet.
From healthcare to homecare, homeland defense to food security, transportation to recreation, products from our family of companies are transforming the way we live, work and play.
Based in Denver, Colorado, NanoSphere Health Sciences is a biotechnology firm specializing in the creation of NanoSphere™ delivery systems for the supplement, nutraceutical, over-the-counter, pharmaceutical industries and beyond. Its patent-pending NanoSphere delivery systems and industry-first line of bioavailable NanoSphere Gels represent a significant milestone and one of the most important developments for advancing the non-invasive delivery of biological agents in over 25 years.